vol 2 Figure 11 Trends in the number of incident cases of ESRD in thousands by modality in the US population 19802012 Vol 2 ESRD Ch 1 2 Data Source Reference tables A22 and A23 Adjusted for age sex and race The standard population was the US population in 2011 ID: 1041418
Download Presentation The PPT/PDF document "Data Source: Reference table D1. Abbrevi..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
1.
2. Data Source: Reference table D1. Abbreviation: ESRD, end-stage renal disease. vol 2 Figure 1.1 Trends in the number of incident cases of ESRD, in thousands, by modality, in the U.S. population, 1980-2012Vol 2, ESRD, Ch 12
3. Data Source: Reference tables A.2(2) and A.2(3). *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.vol 2 Figure 1.2 Trends in the adjusted* incidence rate of ESRD, per million/year (bars; scale on right), and annual percent change in the adjusted* incidence rate of ESRD (lines; scale on left) in the U.S. population, 1980-2012Vol 2, ESRD, Ch 13
4. Vol 2, ESRD, Ch 14vol 2 Figure 1.3 Map of the adjusted* incidence rate of ESRD, per million/year, by state, in the U.S. population, 2012Data Source: Reference table A.9, and special analyses, USRDS ESRD Database. *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.
5. Vol 2, ESRD, Ch 15Data Source: Reference table: A.10, A.11, and Special Analyses, USRDS ESRD Database. *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Listed from lowest to highest rate per million/year. Abbreviations: Af Am, African American; ESRD, end-stage renal disease; Hisp, Hispanic; N Am, Native American.vol 2 Table 1.1 Adjusted* incidence rate of ESRD, per million/year, and percentage distribution of diabetes, race and ethnicity among incident ESRD patients, by ESRD network, 2012Net-workStates in NetworkTotal patients% of totalRate per million/yearMean age% DiabeticRaceEthnicity% White% Af Am% N Am%Asian%Hisp1CT, MA, ME, NH, RI VT3,6543.2256.464.139.282.414.50.22.89.616AK, ID, MT, OR, WA3,3802.9269.361.743.282.46.13.48.07.815AZ, CO, NV, NM, UT, WY5,3374.6301.561.147.678.18.38.84.524.37FL7,4446.5319.564.239.667.830.00.22.015.42NY6,9646.1325.764.143.263.030.50.36.114.36NC, SC, GA9,9188.6328.060.640.444.053.70.71.52.35MD, DC, VA, WV6,5965.7334.762.539.350.645.90.13.22.712IA, KS, MO, NE4,2293.7336.963.340.476.621.00.81.54.511MI, MN, ND, SD, WI7,1516.2337.563.239.971.822.72.82.53.74DE, PA5,1304.5341.065.041.574.723.70.11.53.817N. CA, HI, GUAM, AS5,7925.0358.562.449.056.311.60.631.320.28AL, MS, TN6,3105.5364.461.243.051.047.60.40.91.43NJ, PR5,0924.4366.763.949.571.524.70.03.638.713AR, LA, OK4,6514.1372.461.344.156.138.83.91.13.310IL5,2104.5395.563.638.464.730.90.33.912.39IN, KY, OH9,1528.0404.063.344.576.622.20.11.12.418S. CA8,8167.7420.462.848.872.912.30.513.941.314TX9,8008.5426.460.354.773.623.50.22.640.9All 114,813100.0353.262.544.066.327.41.15.114.8
6. Vol 2, ESRD, Ch 16vol 2 Figure 1.4 Trends in (a) ESRD incident cases, in thousands, and (b) adjusted* ESRD incidence rate, per million/year, by age group, in the U.S. population, 1980-2012Data Source: Reference tables A.1, A.2(2). *Adjusted for sex and race. The standard population is the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.(a) Incident Cases(b) Incidence Rates
7. Vol 2, ESRD, Ch 17vol 2 Figure 1.5 Trends in (a) ESRD incident cases, in thousands, and (b) adjusted* ESRD incidence rate, per million/year, by race, in the U.S. population, 1980-2012Data Source: Reference tables A.1, A.2(2). *Adjusted for age and sex; the standard population was the U.S. population in 2011. Panel b: ~Estimate shown is imprecise due to small sample size and may be unstable over time. The line for Native Americans has a discontinuity because of unreliable data for that year. Abbreviations: Af Am, African American; ESRD, end-stage renal disease; N Am, Native American.(a) Incident Cases(b) Incidence Rates
8. Vol 2, ESRD, Ch 18vol 2 Figure 1.6 Trends in (a) ESRD incident cases, in thousands, and (b) adjusted* ESRD incidence rate, per million/year, by Hispanic ethnicity, in the U.S. population, 1996-2012Data Source: Reference tables A.1, A.2(3). *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.(a) Incident Cases(b) Incidence Rates
9. Vol 2, ESRD, Ch 19vol 2 Figure 1.7 Trends in (a) ESRD incident cases, in thousands, and (b) adjusted* ESRD incidence rate, per million/year, by primary cause of ESRD, in the U.S. population, 1980-2012(a) Incident Cases(b) Incidence RatesData Source: Reference tables A.1, A.2(2). *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.
10. Vol 2, ESRD, Ch 110vol 2 Figure 1.8 Trends in the sex-adjusted incidence rate* of ESRD due to diabetes as the primary cause, per million/year, by age, race, and ethnicity, for black/African Americans, in the U.S. population, 1980-2012 Data Source: Special analyses, USRDS ESRD Database. *Rates are based on three-year rolling averages, and they are adjusted for sex. The standard population is the U.S. population in 2011. Abbreviations: Af Am, African American; ESRD, end-stage renal disease.
11. Vol 2, ESRD, Ch 111vol 2 Figure 1.8 Trends in the sex-adjusted incidence rate* of ESRD due to diabetes as the primary cause, per million/year, by age, race, and ethnicity, for whites, in the U.S. population, 1980-2012 Data Source: Special analyses, USRDS ESRD Database. *Rates are based on three-year rolling averages, and they are adjusted for sex. The standard population is the U.S. population in 2011. Abbreviations: ESRD, end-stage renal disease.
12. Vol 2, ESRD, Ch 112vol 2 Figure 1.8 Trends in the sex-adjusted incidence rate* of ESRD due to diabetes as the primary cause, per million/year, by age, race, and ethnicity, for Hispanics, in the U.S. population, 1980-2012 Data Source: Special analyses, USRDS ESRD Database. *Rates are based on three-year rolling averages, and they are adjusted for sex. The standard population is the U.S. population in 2011. Abbreviations: Hisp, Hispanic; ESRD, end-stage renal disease.
13. Vol 2, ESRD, Ch 113vol 2 Figure 1.9 Trends in the sex-adjusted incidence rate* of ESRD due to hypertension as the primary cause, per million/year, by age, race, and ethnicity, for blacks/African Americans, in the U.S. population, 1980-2012Data Source: Special analyses, USRDS ESRD Database. *Rates are based on three-year rolling averages, and they are adjusted for sex. The standard population is the U.S. population in 2011. Abbreviations: Af Am, African American; ESRD, end-stage renal disease.
14. Vol 2, ESRD, Ch 114vol 2 Figure 1.9 Trends in the sex-adjusted incidence rate* of ESRD due to hypertension as the primary cause, per million/year, by age, race, and ethnicity, for whites, in the U.S. population, 1980-2012Data Source: Special analyses, USRDS ESRD Database. *Rates are based on three-year rolling averages, and they are adjusted for sex. The standard population is the U.S. population in 2011. Abbreviations: ESRD, end-stage renal disease.
15. Vol 2, ESRD, Ch 115vol 2 Figure 1.9 Trends in the sex-adjusted incidence rate* of ESRD due to hypertension as the primary cause, per million/year, by age, race, and ethnicity, for Hispanics, in the U.S. population, 1980-2012Data Source: Special analyses, USRDS ESRD Database. *Rates are based on three-year rolling averages, and they are adjusted for sex. The standard population is the U.S. population in 2011. Abbreviations: Hisp, Hispanic; ESRD, end-stage renal disease.
16. Data Source: Reference table D.1. Abbreviation: ESRD, end-stage renal disease.vol 2 Figure 1.10 Trends in the number of prevalent cases of ESRD, in thousands, by modality, in the U.S. population, 1980-2012Vol 2, ESRD, Ch 116
17. Data Source: Reference table: B.2(2), and B.2(3). *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.vol 2 Figure 1.11 Trends in the adjusted* ESRD prevalence per million (bars; scale on left), and annual percent change in adjusted* prevalence of ESRD (lines; scale on right), in the U.S. population, 1980-2012Vol 2, ESRD, Ch 117
18. Vol 2, ESRD, Ch 118vol 2 Figure 1.12 Map of the adjusted* prevalence of ESRD per million, by state, in the U.S. population, 2012Data Source: Reference table B.9, and special analyses, USRDS ESRD Database. *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.
19. Vol 2, ESRD, Ch 119Data Source: Special analyses, USRDS ESRD Database. *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Listed from lowest to highest prevalence per million. Abbreviations: Af Am, African American; ESRD, end-stage renal disease; Hisp, Hispanic; N Am, Native American.vol 2 Table 1.2 Adjusted* prevalence of dialysis, per million, and percentage distribution of diabetes, race, and ethnicity among prevalent dialysis patients, by ESRD network, 2012 Race EthnicityNetworkStates in NetworkTotal patients% of totalPrevalence per millionMean age% Diabetic% White% Af Am% N Am%Asian% Hisp16AK, ID, MT, OR, WA11,1872.777261.944.775.99.54.010.311.01CT, MA, ME, NH, RI VT12,4223.083164.940.274.221.40.33.411.715AZ, CO, NV, NM, UT, WY19,1354.792961.752.670.211.213.25.031.612IA, KS, MO, NE13,5313.396162.941.566.130.91.11.75.811MI, MN, ND, SD, WI24,1385.91,04863.141.761.032.73.22.94.79IN, KY, OH27,9976.91,22462.544.363.535.20.11.02.84DE, PA17,2644.21,23763.541.461.036.60.11.95.27FL24,6616.01,24162.940.754.143.00.32.117.917N. CA, HI, GUAM, AS21,6965.31,29562.851.149.015.40.833.723.62NY26,6166.51,32063.541.249.941.40.46.816.610IL17,6164.31,34262.739.653.442.30.23.814.83NJ, PR17,4364.31,35063.547.359.533.40.13.937.713AR, LA, OK16,0413.91,38760.143.540.154.04.41.33.75MD, DC, VA, WV23,7705.81,40161.939.435.660.40.33.14.018S. CA34,8508.51,42962.649.970.015.60.413.548.614TX38,7129.51,44460.354.066.530.20.32.345.86NC, SC, GA38,7069.51,54460.340.628.968.70.71.32.98AL, MS, TN22,6655.61,55960.241.535.563.20.50.61.2All 408,711100.01,25162.144.654.937.61.45.417.9
20. Vol 2, ESRD, Ch 120Data Source: Special analyses, USRDS ESRD Database. *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Listed from lowest to highest prevalence per million. Abbreviations: Af Am, African American; ESRD, end-stage renal disease; Hisp, Hispanic; N Am, Native American.vol 2 Table 1.3 Adjusted* prevalence of kidney transplant patients, per million, and percentage distribution of diabetes, race, and ethnicity among prevalent transplant patients, by ESRD network, 2012 RaceEthnicity NetworkStates in NetworkTotal patients% of totalPrevalence per millionMean age% Diabetic% White% Af Am% N Am%Asian% Hisp13AR, LA, OK5,5543.0482.152.224.064.030.92.62.03.57FL9,6495.2482.354.922.371.123.00.53.419.514TX13,0897.0482.351.425.375.317.70.44.037.516AK, ID, MT, OR, WA7,2053.9498.353.322.983.45.21.88.67.56NC, SC, GA12,5546.7501.852.522.855.040.80.82.33.415AZ, CO, NV, NM, UT, WY10,4365.6506.252.928.383.05.85.44.423.418S. CA12,9857.0525.651.719.873.99.90.413.341.58AL, MS, TN7,8044.2540.251.921.460.637.60.21.31.59IN, KY, OH12,9376.9565.753.024.879.717.60.11.62.41CT, MA, ME, NH, RI VT8,5384.6568.153.920.282.511.40.33.88.62NY12,1536.5587.453.421.364.823.20.56.918.217N. CA, HI, GUAM, AS9,7645.2589.853.322.161.88.90.724.624.412IA, KS, MO, NE8,3284.5593.753.323.882.013.91.42.25.24DE, PA8,8084.7626.054.623.074.820.50.22.64.23NJ, PR7,2553.9629.753.623.364.020.30.25.729.15MD, DC, VA, WV11,0465.9647.253.622.055.138.00.34.84.610IL9,1914.9687.752.823.369.422.60.44.914.711MI, MN, ND, SD, WI16,2568.7707.753.926.379.914.01.93.53.5All 186,303100.0562.453.023.070.619.61.05.714.5
21. Vol 2, ESRD, Ch 121vol 2 Figure 1.13 Trends in (a) prevalent ESRD cases and (b) the adjusted* prevalence of ESRD, per million, by age group, in the U.S. population, 1980-2012(a) Prevalent Cases(b) Prevalence per millionData Source: Reference tables B.1, B.1(2). *Point prevalence on December 31 of each year; Adjusted for sex and race; The standard population was the U.S. population in 2011 ESRD patients. Abbreviation: ESRD, end-stage renal disease.
22. Vol 2, ESRD, Ch 122vol 2 Figure 1.14 Trends in (a) prevalent ESRD cases and (b) the adjusted* prevalence of ESRD, per million, by race, in the U.S. population, 1980-2012 (a) Prevalent Cases(b) Prevalence per millionData Source: Reference tables B.1, B.1(2). *Point prevalence on December 31 of each year; Adjusted for age and sex; The standard population was the U.S. population in 2011 ESRD patients. Panel b: ~Estimate shown is imprecise due to small sample size and may be unstable over time. The line for Native Americans has a discontinuity because of unreliable data for that year. Abbreviations: Af Am, African American; ESRD, end-stage renal disease; N Am, Native American.
23. Vol 2, ESRD, Ch 123vol 2 Figure 1.15 Trends in (a) prevalent ESRD cases and (b) the adjusted* prevalence of ESRD, per million, by ethnicity, in the U.S. population, 1980-2012(a) Prevalent Cases(b) Prevalence per millionData Source: Reference tables B.1, B.1(3). *Point prevalence on December 31 of each year; Adjusted for age, sex, and race; The standard population was the U.S. population in 2011 ESRD patients. Abbreviation: ESRD, end-stage renal disease.
24. Vol 2, ESRD, Ch 124vol 2 Figure 1.16 Trends in (a) prevalent ESRD cases and (b) adjusted* prevalence of ESRD, per million, by primary cause of ESRD, in the U.S. population, 1980-2012(a) Prevalent Cases(b) Prevalence per millionData Source: Reference tables B.1, B.1(2). *Point prevalence on December 31 of each year; Adjusted for age, sex, and race, The standard population was the U.S. population in 2011 ESRD patients. Abbreviation: ESRD, end-stage renal disease.
25. Vol 2, ESRD, Ch 125 HD PD Tx N%N%N%Age 0-19 5060.53493.82458.720-44 10,37510.51,65018.066123.645-64 38,26838.73,95243.11,35548.365-74 24,52824.81,90020.748517.375+ 25,27725.51,32414.4572.0Sex Male56,84757.45,19756.61,61257.5Female42,10742.63,97843.41,19142.5Race White65,43066.16,41569.92,28881.6Black/African Am28,65929.02,13723.329210.4Native American1,1391.2870.9291.0Asian3,7263.85365.81946.9Ethnicity Hispanic13,70213.81,25113.642015.0Non-Hispanic85,25286.27,92486.42,38385.0Primary cause of ESRD Diabetes43,92244.43,78341.244115.7Hypertension29,11129.42,37325.92579.2Glomerulonephritis6,8897.01,38715.155319.7Cystic kidney 1,5511.64765.242915.3Other urologic4100.4610.7541.9Other Cause10,76210.96827.450117.9Unknown/missing6,3096.44134.556820.3All98,954100.09,175100.02,803100.0vol 2 Table 1.4 Number and percentage of incident cases of hemodialysis (HD), peritoneal dialysis (PD), and transplantation (Tx) by age, sex, race, ethnicity, and primary ESRD diagnosis, in the U.S. population, 2012Data Source: Special analyses, USRDS ESRD Database. Abbreviation: African Am, African American; ESRD, end-stage renal disease.
26. Data Source: Reference table: D.1.vol 2 Figure 1.17 Trend in the number of incident ESRD patients using home hemodialysis, in thousands, by type of therapy, in the U.S. population, 1980-2012Vol 2, ESRD, Ch 126
27. Vol 2, ESRD, Ch 127HDPD Tx N%N%N%Age 0-19 1,1340.38982.24,9572.820-44 49,84312.48,18720.239,96522.745-64 167,49941.618,13744.789,87651.165-74 95,88923.88,28420.432,47518.575+ 88,14921.95,09912.68,7054.9Sex Male226,20556.221,96854.1104,65459.5Female176,30943.818,63745.971,32440.5Race White221,88755.126,69065.7128,46873.0Black/African Am153,26438.110,53425.935,62820.2Native American5,8391.54761.21,7551.0Asian21,5245.32,9057.210,1275.8Ethnicity Hispanic68,71017.15,91514.635,46720.2Non-Hispanic333,80482.934,69085.4140,51179.8Primary cause of ESRD Diabetes178,01244.214,12034.840,68823.1Hypertension116,26028.910,52825.927,78515.8Glomerulonephritis43,52110.87,93119.548,98027.8Cystic kidney9,5432.41,8954.717,4639.9Other urologic3,0520.83690.93,5152.0Other Cause32,5138.13,6609.020,30611.5Unknown/missing19,6134.92,1025.217,2419.8All402,514100.040,605100.0175,978100.0vol 2 Table 1.5 Number and percentage of prevalent cases of hemodialysis (HD), peritoneal dialysis (PD), and transplantation (Tx) by age, sex, race, ethnicity, and primary ESRD diagnosis, in the U.S. population, 2012Data Source: Special analyses, USRDS ESRD Database. Abbreviation: African Am, African American; ESRD, end-stage renal disease.
28. Data Source: Reference table: D.1. December 31 prevalent ESRD patients; peritoneal dialysis consists of CAPD and CCPD only. Abbreviations: CAPD, continuous ambulatory peritoneal dialysis; CCPD, continuous cycler peritoneal dialysis; ESRD, end-stage renal disease.vol 2 Figure 1.18 Trend in the number of prevalent ESRD patients using home dialysis, in thousands, by type of therapy, in the U.S. population, 1980-2012Vol 2, ESRD, Ch 128
29. Vol 2, ESRD, Ch 129vol 2 Figure 1.19 Trend in the distribution of payer type among incident ESRD patients using hemodialysis, 1978-2012(a) HemodialysisData Source: Special analyses, USRDS ESRD Database. Abbreviations: ESRD, end-stage renal disease.
30. Vol 2, ESRD, Ch 130vol 2 Figure 1.19 Trend in the distribution of payer type among incident ESRD patients using peritoneal dialysis, 1978-2012(b) Peritoneal DialysisData Source: Special analyses, USRDS ESRD Database. Peritoneal dialysis consists of CAPD and CCPD only. Abbreviations: CAPD, continuous ambulatory peritoneal dialysis; CCPD, continuous cycler peritoneal dialysis; ESRD, end-stage renal disease.
31. Vol 2, ESRD, Ch 131vol 2 Figure 1.19 Trend in the distribution of payer type among incident ESRD patients with transplants, 1978-2012(c) TransplantData Source: Special analyses, USRDS ESRD Database. Abbreviations: ESRD, end-stage renal disease.
32. Vol 2, ESRD, Ch 132vol 2 Figure 1.20 Trend in the distribution of payer type among prevalent ESRD patients using hemodialysis, 1978-2012 (a) HemodialysisData Source: Special analyses, USRDS ESRD Database. Point prevalence on December 31 of each year. Abbreviations: ESRD, end-stage renal disease.
33. Vol 2, ESRD, Ch 133vol 2 Figure 1.20 Trend in the distribution of payer type among prevalent ESRD patients using peritoneal dialysis, 1978-2012 (b) Peritoneal DialysisData Source: Special analyses, USRDS ESRD Database. Point prevalence on December 31 of each year; Peritoneal dialysis consists of CAPD and CCPD only. Abbreviations: CAPD, continuous ambulatory peritoneal dialysis; CCPD, continuous cycler peritoneal dialysis; ESRD, end-stage renal disease.
34. Vol 2, ESRD, Ch 134vol 2 Figure 1.20 Trend in the distribution of payer type among prevalent ESRD patients with transplants, 1978-2012 (c) TransplantData Source: Special analyses, USRDS ESRD Database. Point prevalence on December 31 of each year. Abbreviations: ESRD, end-stage renal disease.
35. Vol 2, ESRD, Ch 135None0-12 mo.>12 mo.*% of patients41.330.827.9Mean Age61.662.763.7Age 0-1934.331.234.420-2447.629.023.345-6442.730.926.465-7438.731.330.075+38.930.730.3SexMale39.131.829.1Female38.832.328.9RaceWhite37.236.526.4Black42.132.225.7Native Amer.45.030.224.7Asian39.630.829.6Hispanic ethnicityYes47.730.921.4No39.731.029.3None0-12 mo.>12 mo.*Vascular AccessFistula10.536.053.5Catheter49.330.120.6Graft19.936.843.3ESA use3.842.553.7Dietary care0.745.753.5eGFR at RRT start*<553.024.822.25-<1037.831.730.510-<1534.634.131.3≥1542.832.025.1Primary diagnosisDiabetes35.334.630.1Hypertension41.931.226.8Glomerulonephritis31.831.436.8Cystic kidney17.327.355.3vol 2 Table 1.6 Distribution of the reported duration of pre-ESRD nephrology care, by demographic and clinical characteristics, among incident ESRD patients in the U.S., 2012Data Source: Reference tables C.8, C.10, and special analyses, USRDS ESRD Database. eGFR calculated using the CKD-EPI equation (CKD-EPI eGFR (ml/min/1.73 m2). Abbreviations: CKD-EPI; chronic kidney disease epidemiology calculation; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; ESA, erythropoiesis-stimulating agents; RRT, renal replacement therapy. *All these numbers are percent within row, except mean age.
36. Data Source: Special analyses, USRDS ESRD Database. Abbreviations: ESA, erythropoiesis-stimulating agents; ESRD, end-stage renal disease.vol 2 Figure 1.21 (a) Trend in Hgb levels, among incident ESRD patients, 1995-2012Vol 2, ESRD, Ch 136
37. Data Source: Special analyses, USRDS ESRD Database. Abbreviations: ESA, erythropoiesis-stimulating agents; ESRD, end-stage renal disease.vol 2 Figure 1.21 (b) Trend in the percentage of patients who received pre-ESRD erythropoiesis-stimulating agent (ESA) treatment, among incident ESRD patients, 1995-2012Vol 2, ESRD, Ch 137
38. Vol 2, ESRD, Ch 138Data Source: Special analyses, USRDS ESRD Database. eGFR calculated using the CKD-EPI equation (CKD-EPI eGFR (ml/min/1.73 m2). Abbreviations: Af Am, African American; CKD-EPI; chronic kidney disease epidemiology calculation; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; Hgb; hemoglobin; LDL, low-density lipoprotein; RRT, renal replacement therapy; Triglycer, triglycerides. vol 2 Table 1.7 Mean laboratory values, by age, sex, race/ethnicity, and primary ESRD diagnosis, among incident ESRD patients, 2012Serum albuminHgb (g/dl)Total cholesterol (mg/dl)LDL (mg/dl)HDL (mg/dl)Triglycer (mg/dl)HbA1ceGFR at RRT startAge20-443.39.4169.6100.640.6162.57.09.645-643.29.5159.791.240.0156.66.910.265-743.39.6149.182.839.7146.26.610.675+3.29.7140.476.140.6127.86.410.6SexMale3.39.7147.583.737.8144.86.710.7Female3.29.5164.191.743.5154.96.810.0Race/ethnicity White3.39.7150.483.638.8152.96.710.7Black/Af Am3.29.3162.094.543.0137.56.79.9Native American2.99.5153.984.341.2152.46.79.7Asian3.39.5158.989.241.4155.16.79.0Hispanic3.39.5156.588.639.7159.86.89.9Primary diagnosis Diabetes3.29.5153.286.240.1151.17.010.6Hypertension3.39.6151.586.240.6136.56.210.0Glomerulonephritis3.39.6172.099.141.9166.26.09.5Cystic kidney3.810.3160.187.740.9153.95.79.5All3.39.6154.287.040.1148.96.710.4
39. Vol 2, ESRD, Ch 139vol 2 Figure 1.22 Trend in the distribution of eGFR (ml/min/1.73 m2) among incident ESRD patients, 1996-2012Data Source: Special analyses, USRDS ESRD Database. eGFR calculated using the CKD-EPI equation (CKD-EPI eGFR (ml/min/1.73 m2). Abbreviations: CKD-EPI; chronic kidney disease epidemiology calculation; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease.